Vilen Lipatov

ECA Economics GmbH

Avenue Louise 500

Brussels

Belgium

SCHOLARLY PAPERS

11

DOWNLOADS

1,005

SSRN CITATIONS

7

CROSSREF CITATIONS

5

Scholarly Papers (11)

1.

Standard Essential Patents: Who is Really Holding Up (and When)?

Number of pages: 34 Posted: 23 Feb 2013
Gregor Langus, Vilen Lipatov and Damien Neven
ECA Economics GmbH, ECA Economics GmbH and Graduate Institute of International and Development Studies (IHEID)
Downloads 400 (93,177)
Citation 8

Abstract:

Loading...

standard essential patent, injunctions, hold up, reverse hold up

2.

A Journey from a Corruption Port to a Tax Haven

CESifo Working Paper Series No. 3620
Number of pages: 34 Posted: 27 Oct 2011
Shafik Hebous and Vilen Lipatov
International Monetary Fund and ECA Economics GmbH
Downloads 116 (297,455)

Abstract:

Loading...

tax havens, tax avoidance, tax evasion, multinational firms, corruption

3.

Upward Pricing Pressure of Mergers Weakening Vertical Relationships

CESifo Working Paper Series No. 5692
Number of pages: 8 Posted: 04 Feb 2016
Gregor Langus and Vilen Lipatov
ECA Economics GmbH and ECA Economics GmbH
Downloads 115 (299,322)

Abstract:

Loading...

UPP, supply relationship, merger effects

4.

Opportunities to Divert, Firm Value, and Taxation: Theory and Evidence from European Firms

Number of pages: 38 Posted: 23 Sep 2011
Robert Krämer and Vilen Lipatov
Goethe University Frankfurt - Faculty of Economics and Business Administration and ECA Economics GmbH
Downloads 78 (383,733)
Citation 1

Abstract:

Loading...

corporate governance, corporate taxation

5.

A Decentralization Theorem of Taxation

SAFE Working Paper No. 105
Number of pages: 19 Posted: 20 May 2015
Vilen Lipatov and Alfons J. Weichenrieder
ECA Economics GmbH and Goethe University Frankfurt - Department of Applied Econometrics and International Economic Policy
Downloads 68 (413,941)

Abstract:

Loading...

fiscal federalism, taxing rights, decentralization theorem

6.

The Effect of Corporate Taxation and Ownership on Raising Shareholder Capital

CESifo Working Paper Series No. 4436
Number of pages: 37 Posted: 01 Nov 2013
Robert Krämer and Vilen Lipatov
Goethe University Frankfurt - Faculty of Economics and Business Administration and ECA Economics GmbH
Downloads 67 (417,244)

Abstract:

Loading...

corporate taxation, corporate governance, managerial diversion, shareholder capital, tax enforcement

7.

Does Envelopment Through Data Advantage Call for New Regulation?

CESifo Working Paper No. 8932
Number of pages: 35 Posted: 16 Mar 2021
Gregor Langus and Vilen Lipatov
ECA Economics GmbH and ECA Economics GmbH
Downloads 61 (437,670)

Abstract:

Loading...

8.

Optimal Taxation Under Regional Inequality

CESifo Working Paper Series No. 5152
Number of pages: 40 Posted: 16 Jan 2015
University of Siegen, ECA Economics GmbH and University of Siegen
Downloads 60 (441,252)
Citation 1

Abstract:

Loading...

optimal taxation, redistribution, regional inequality, migration, multi-dimensional screening, delayed optimal control

9.

Compliance Dynamics Generated by Social Interaction Rules

CESifo Working Paper Series No. 4767
Number of pages: 39 Posted: 15 May 2014
Vilen Lipatov
ECA Economics GmbH
Downloads 26 (601,011)

Abstract:

Loading...

social interaction, compliance, random matching, behavioral rule, learning

10.

A Note on Partial Merchant Internalization and MIT Threshold

CESifo Working Paper Series No. 5684
Number of pages: 13 Posted: 05 Feb 2016
Vilen Lipatov
ECA Economics GmbH
Downloads 12 (701,864)

Abstract:

Loading...

MIT, merchant internalization, payment cards, two-sided markets

11.

Dominance and the Pre-Emption of Competition Following the Servier and Paroxetine GSK Judgments

CEPR Discussion Paper No. DP14019
Number of pages: 33 Posted: 07 Oct 2019
Vilen Lipatov, Damien J Neven and Georges Siotis
ECA Economics GmbH, Graduate Institute of International and Development Studies (IHEID) and Universidad Carlos III de Madrid - Department of Economics
Downloads 2 (781,767)
  • Add to Cart

Abstract:

Loading...

Abuse of dominance, foreclosure, Non-price competition, Pharmaceutical industry